|
Q4 2018
Filed on Feb 14, 2019
|
74,100
|
$108.23 - $136.84
$8.02M - $10.1M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
67,281
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
414,100
|
$122.84 - $147.84
$50.9M - $61.2M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
50,000
|
$108.23 - $136.84
$5.41M - $6.84M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,722,400
|
$8.65 - $16.28
$14.9M - $28M
|
|
Insys Therapeutics Inc New
|
Q4 2018
Filed on Feb 14, 2019
|
3,028,354
|
N/A
|
|
Inotek Pharmaceuticals Corp
|
Q4 2018
Filed on Feb 14, 2019
|
7,000,000
|
N/A
|
|
Biomarin Pharmaceutical Inc
|
Q4 2018
Filed on Feb 14, 2019
|
500,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
20,000
|
N/A
|
|
Biomarin Pharmaceutical Inc
|
Q4 2018
Filed on Feb 14, 2019
|
500,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
884,000
|
$115.94 - $166.74
$102M - $147M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
633,900
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
330,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
98,200
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
4,806,900
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
843,205
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
513,200
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
251,383
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
171,100
|
$87.74 - $125.01
$15M - $21.4M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
290,800
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
200,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
136,900
|
$26.5 - $36.64
$3.63M - $5.02M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
356,608
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
4,246,196
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
60,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
875,400
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
50,000
|
$23.62 - $42.29
$1.18M - $2.11M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
4,118,903
|
N/A
|
|
Novelion Therapeutics Inc
|
Q2 2018
Filed on Aug 14, 2018
|
100,000
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
95,214
|
$6.91 - $9.55
$658K - $909K
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
200,000
|
$16.77 - $24.71
$3.35M - $4.94M
|
|
Achillion Pharmaceuticals In
|
Q1 2018
Filed on May 15, 2018
|
8,170,973
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
967,859
|
$14.05 - $20.2
$13.6M - $19.6M
|
|
Valeant Pharmaceuticals Intl
|
Q1 2018
Filed on May 15, 2018
|
76,800
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
71,700
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
711,710
|
$46.55 - $57.38
$33.1M - $40.8M
|
|
|
Q1 2018
Filed on May 15, 2018
|
4,754,386
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
220,700
|
$46.03 - $61.28
$10.2M - $13.5M
|
|
|
Q1 2018
Filed on May 15, 2018
|
254,200
|
$76.55 - $87.26
$19.5M - $22.2M
|
|
Orexigen Therapeutics Inc
|
Q1 2018
Filed on May 15, 2018
|
5,210,000
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
1,835,188
|
N/A
|
|
Momenta Pharmaceuticals Inc
|
Q1 2018
Filed on May 15, 2018
|
1,125,900
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,472,700
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
50,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
831,274
|
N/A
|
|
Dimension Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
5,397,698
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
337,588
|
$10.51 - $17.22
$3.55M - $5.81M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
350,000
|
$16.75 - $20.8
$5.86M - $7.28M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
50,000
|
N/A
|
|
Synergy Pharmaceuticals Del
|
Q4 2017
Filed on Feb 14, 2018
|
13,621,443
|
N/A
|
|